165 related articles for article (PubMed ID: 18310305)
21. The monoclonal antibody CHO-131 binds to a core 2 O-glycan terminated with sialyl-Lewis x, which is a functional glycan ligand for P-selectin.
Walcheck B; Leppanen A; Cummings RD; Knibbs RN; Stoolman LM; Alexander SR; Mattila PE; McEver RP
Blood; 2002 Jun; 99(11):4063-9. PubMed ID: 12010808
[TBL] [Abstract][Full Text] [Related]
22. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
[TBL] [Abstract][Full Text] [Related]
23. L- and P-selectins collaborate to support leukocyte rolling in vivo when high-affinity P-selectin-P-selectin glycoprotein ligand-1 interaction is inhibited.
Ridger VC; Hellewell PG; Norman KE
Am J Pathol; 2005 Mar; 166(3):945-52. PubMed ID: 15743805
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin.
Maaheimo H; Renkonen R; Turunen JP; Penttilä L; Renkonen O
Eur J Biochem; 1995 Dec; 234(2):616-25. PubMed ID: 8536711
[TBL] [Abstract][Full Text] [Related]
25. Sialyl-Lewis x-independent infection of human myeloid cells by Anaplasma phagocytophilum strains HZ and HGE1.
Sarkar M; Reneer DV; Carlyon JA
Infect Immun; 2007 Dec; 75(12):5720-5. PubMed ID: 17893131
[TBL] [Abstract][Full Text] [Related]
26. A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity.
Sackstein R; Dimitroff CJ
Blood; 2000 Oct; 96(8):2765-74. PubMed ID: 11023510
[TBL] [Abstract][Full Text] [Related]
27. Core2 beta-1,6-N-acetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P-selectin.
Kumar R; Camphausen RT; Sullivan FX; Cumming DA
Blood; 1996 Nov; 88(10):3872-9. PubMed ID: 8916952
[TBL] [Abstract][Full Text] [Related]
28. Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins.
Marathe DD; Buffone A; Chandrasekaran EV; Xue J; Locke RD; Nasirikenari M; Lau JT; Matta KL; Neelamegham S
Blood; 2010 Feb; 115(6):1303-12. PubMed ID: 19996411
[TBL] [Abstract][Full Text] [Related]
29. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin.
Snapp KR; Ding H; Atkins K; Warnke R; Luscinskas FW; Kansas GS
Blood; 1998 Jan; 91(1):154-64. PubMed ID: 9414280
[TBL] [Abstract][Full Text] [Related]
30. Glycosylation in the control of selectin counter-receptor structure and function.
Lowe JB
Immunol Rev; 2002 Aug; 186():19-36. PubMed ID: 12234359
[TBL] [Abstract][Full Text] [Related]
31. PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow.
Zou X; Shinde Patil VR; Dagia NM; Smith LA; Wargo MJ; Interliggi KA; Lloyd CM; Tees DF; Walcheck B; Lawrence MB; Goetz DJ
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C415-24. PubMed ID: 15814589
[TBL] [Abstract][Full Text] [Related]
32. Identification of N-terminal residues on P-selectin glycoprotein ligand-1 required for binding to P-selectin.
Liu W; Ramachandran V; Kang J; Kishimoto TK; Cummings RD; McEver RP
J Biol Chem; 1998 Mar; 273(12):7078-87. PubMed ID: 9507018
[TBL] [Abstract][Full Text] [Related]
33. Core 1-derived O-glycans are essential E-selectin ligands on neutrophils.
Yago T; Fu J; McDaniel JM; Miner JJ; McEver RP; Xia L
Proc Natl Acad Sci U S A; 2010 May; 107(20):9204-9. PubMed ID: 20439727
[TBL] [Abstract][Full Text] [Related]
34. Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin.
Rodgers SD; Camphausen RT; Hammer DA
Biophys J; 2000 Aug; 79(2):694-706. PubMed ID: 10920004
[TBL] [Abstract][Full Text] [Related]
35. Structure and function of the selectin ligand PSGL-1.
Cummings RD
Braz J Med Biol Res; 1999 May; 32(5):519-28. PubMed ID: 10412562
[TBL] [Abstract][Full Text] [Related]
36. N-terminal residues in murine P-selectin glycoprotein ligand-1 required for binding to murine P-selectin.
Xia L; Ramachandran V; McDaniel JM; Nguyen KN; Cummings RD; McEver RP
Blood; 2003 Jan; 101(2):552-9. PubMed ID: 12393631
[TBL] [Abstract][Full Text] [Related]
37. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro.
Davenpeck KL; Brummet ME; Hudson SA; Mayer RJ; Bochner BS
J Immunol; 2000 Sep; 165(5):2764-72. PubMed ID: 10946308
[TBL] [Abstract][Full Text] [Related]
38. Equine PSGL-1 modifications required for P-selectin binding.
Xu J; Cai J; Suresh M; Peek SF; Darien BJ
Vet Immunol Immunopathol; 2009 Sep; 131(1-2):33-43. PubMed ID: 19403178
[TBL] [Abstract][Full Text] [Related]
39. Mouse P-selectin glycoprotein ligand-1: molecular cloning, chromosomal localization, and expression of a functional P-selectin receptor.
Yang J; Galipeau J; Kozak CA; Furie BC; Furie B
Blood; 1996 May; 87(10):4176-86. PubMed ID: 8639776
[TBL] [Abstract][Full Text] [Related]
40. PSGL-1 function in immunity and steady state homeostasis.
Carlow DA; Gossens K; Naus S; Veerman KM; Seo W; Ziltener HJ
Immunol Rev; 2009 Jul; 230(1):75-96. PubMed ID: 19594630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
